Skip to main content
. Author manuscript; available in PMC: 2016 Oct 3.
Published in final edited form as: Gynecol Oncol. 2011 Oct 19;124(1):148–152. doi: 10.1016/j.ygyno.2011.09.037

Table 3.

Association between SNCG immunoexpression and the clinical variables.

Variables (group 2 vs group 1) p value Odds ratio (p vs. n)
Age 0.002
Stage 0.032 2.075
Tumor size 0.586 1.33
LVI <0.001 0.275
Depth of myometrial invasion 0.031 1.926
Grade_FIGO <0.001 5.183
Subtype <0.001 0.139
Recurrence 0.006 0.337
Status 0.006 2.509

Age as continuous variable.

Stage: Group 1: stages I and II; Group 2: stages III and IV.

Lympho-vascular invasion (LVI): Group 1: no; Group 2: yes.

Depth of myometrial invasion: Group 1: <=50%; Group 2: >50%.

Histologic Grade: Group 1: FIGO Grades 1 and 2; Group 2: FIGO Grade 3.

Subtype: Group 1: endometrioid; Group 2: others.

Recurrence: Group 1: no; Group 2: all others.

Status: Group 1: ANED; Group 2: all others.